News
Global pharmaceutical company Eli Lilly (NYSE:LLY) reported Q2 CY2025 results exceeding the market’s revenue expectations, ...
The obesity market still only has two clear leaders with approved GLP-1 medications, and frontrunners Eli Lilly and Novo ...
4hon MSN
If You'd Invested $1,000 in Eli Lilly (LLY) Stock 5 Years Ago, Here's How Much You'd Have Today
Over the past five years, Eli Lilly stock has risen roughly 320% as of market close Aug. 11. Meanwhile, the company has ...
Days after President Donald Trump called on drugmakers to offer direct-to-consumer distribution of their products in the U.S.
Global News - Inquirer.net on MSN4h
Will China’s home-grown obesity drugs reshape global weight loss market?
July, video editor Meng Meng, 38, has been injecting herself with a weekly weight loss drug, hoping it will finally help her ...
In a phase 3 trial, the daily GLP-1 pill has shown "meaningful weight loss" and similar side effects to injectable GLP-1 ...
And it’s a problem with humankind in general. We do tend to crave quick fixes, often in pharmaceutical form. That’s why Henry Dimbleby, a food campaigner and founder of Leon, called Ozempic “the ...
Recent medical news supports the reasoning behind the innovative Wellness Incentive Program offered by Teachers Health Trust ...
The report delves into various aspects of health and wellness, including nutrients & supplements, skin health, physical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback